23Aug
Protests in Brazil exposures Gilead’s greed to block generic sofosbuvir
In Rio de Janeiro activists demand INPI to reject the patent. In São Paulo, activists remembered the deaths due to lack of access in front of Gilead’s office.
Read more4May
Gilead’s patent application on sofosbuvir rejected in Brazil
The Working Group on Intellectual Property of the Brazilian Network for Integration of Peoples (GTPI/Rebrip), a coalition of civil society organizations and activists coordinated by the Brazilian Interdisciplinary Aids Association (ABIA), filed several patent oppositions in this case.
Read more